Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management
Open accessAbstract
The treatment strategy for ulcerative colitis [UC] is mainly based on the severity, distribution [proctitis, left-sided, extensive]1 and pattern of disease. The latter includes relapse frequency, disease course, response to previous medications, side effects of medication, and extra-intestinal manifestations. Age at onset, and disease duration are also important factors. It is important to distinguish patients with severe UC necessitating hospital admission from those with mild or moderately active disease who can be managed as outpatients. The best validated and most widely used index for identifying severe UC remains that of Truelove and Witts.2 Patients with bloody stool frequency ≥ 6/day and a tachycardia [> 90 min−1], or temperature > 37.8°C, or anaemia [haemoglobin < 10.5 g/dl], or an elevated erythrocyte sedimentation rate [ESR] [> 30 mm/h] have severe UC. Only one additional criterion in addition to the bloody stool frequency ≥ 6/day is needed to define a severe attack.3,4 In practice, a C-reactive protein [CRP] of 30 mg/l can be substituted for the ESR. A mesalamine 1-g suppository once daily is the preferred initial treatment for mild or moderately active proctitis [EL1]. Mesalamine foam or enemas are an alternative [EL1], but suppositories deliver the drug more effectively to the rectum and are better tolerated [EL3]. Topical mesalamine is more effective than topical steroids [EL1]. Combining topical mesalamine with oral mesalamine or topical steroids is more effective [EL2] Refractory proctitis may require treatment with systemic steroids, immunosuppressants, and/or biologics [EL4] Topical mesalamine [5-aminosalicylic acid or 5-ASA] is the first-line therapy for proctitis. A Cochrane systematic review of 38 clinical trials of treatment of proctitis and left-sided colitis confirmed its superiority over placebo for inducing symptomatic, endoscopic, histological response and remission.5 The pooled odds ratio [OR] was: 8.3 for symptomatic remission (8 trials, 95% confidence interval [CI] 4.28–16.12; p < 0.00001); 5.3 for endoscopic remission [7 trials, 95% CI 3.15–8.92; p < 0.00001]; and 6.3 for histological remission [5 trials, 95% CI 2.74–14.40; p < 0.0001]. Suppositories are more appropriate than enemas in proctitis as they better target the site of inflammation and are more acceptable for patients.6 There is no dose response for topical therapy above a dose of 1 g 5-ASA daily.5,7 Once-daily topical therapy is as effective as divided doses.8,9 A meta-analysis found no difference between oral and topical 5-ASA for induction of remission (risk ratio [RR] for no remission with topical 5-ASA: 0.82, 95% CI 0.52–1.28) or time to remission [24.8 vs 25.5 days, respectively], but the trials included in this meta-analysis enrolled patients with UC of any extent, not specifically proctitis.10 In the single trial that included only patients with proctitis, rectal 5-ASA was more effective than oral 5-ASA alone.11 However, if oral 5-ASA is used alone, 3.6 g of a pH-dependent release preparation appears to be more effective than lower doses or placebo.12 Moreover in patients with proctosigmoiditis, 5-ASA granules rather than tablets are more likely to obtain clinical [78% vs 55%, p < 0.001] and endoscopic [67% vs 43%, p < 0.001] remission.13 The combination of oral and topical 5-ASA is more effective than either alone in patients with disease extending < 50 cm from the anal verge,14 although there is no trial of combination therapy for proctitis alone. Combining topical 5-ASA and topical steroids also helps: beclomethasone dipropionate [3 mg] and 5-ASA [2 g] enemas produced significantly better clinical, endoscopic, and histological improvement than either agent alone.15 Two meta-analyses have shown that topical 5-ASA is more effective than topical steroids, whether assessing symptomatic, endoscopic, or histological remission.16 Consequently topical steroids be to patients who have an or who are to topical A trial shown that g rectal foam alone is more than placebo in inducing remission at in patients with mild to vs p < drug not with topical and endoscopic be confirmed in those with to with oral topical 5-ASA and/or topical Refractory proctitis may require treatment with systemic steroids, or The of proctitis is in to moderately active left-sided ulcerative colitis be with an ≥ 1 with oral mesalamine ≥ [EL1], is more effective than oral or topical or topical steroids alone [EL1]. Topical mesalamine is more effective than topical steroids [EL1]. Once-daily with mesalamine is as effective as divided doses are appropriate in patients with to severe and in those with mild who not to mesalamine [EL1]. beclomethasone dipropionate and as oral in patients with mild to moderately active ulcerative colitis can be in patients with mild to disease who are or to left-sided colitis is an for hospital admission oral and topical 5-ASA is the first-line therapy for mild to moderately active left-sided with an of to remission o
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Strategies for treatment of PSC-IBD do not differ from IBD alone.
“Strategies for treatment of PSC-IBD do not differ from IBD alone.362,372,373”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [362]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P. J., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A. D., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,910 · see citing works
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J., Gasché, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,408 · see citing works
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
Colombel, J., Sandborn, W. J., Reinisch, W., Mantzaris, G. J., Kornbluth, A. A., Rachmilewitz, D., Lichtiger, S., D’Haens, G., Diamond, R. H., Broussard, D. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0904492 · Cited by 3,140 · see citing works
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P. J., Sands, B. E., Hanauer, S. B., Colombel, J., Sandborn, W. J., Assche, G. V., Axler, J. L., Kim, H. J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,892 · see citing works
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,793 · see citing works
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Assche, G. V., Haens, G. D., Carbonez, A., & Rutgeerts, P. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,012 · see citing works
Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Lichtiger, S., Present, D. H., Kornbluth, A. A., Gelernt, I. M., Bauer, J. J., Galler, G. W., Michelassi, F., & Hanauer, S. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302601 · Cited by 1,715 · see citing works
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499 · see citing works
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · see citing works
Sandborn, W. J., Assche, G. V., Reinisch, W., Colombel, J., D’Haens, G., Wolf, D. C., Kron, M., Tighe, M. B., Lazar, A., & Thakkar, R. B. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.032 · Cited by 1,268 · see citing works
Rahier, J. F., Ben-Horin, S., Chowers, Y., Conlon, C., Munter, P. D., D’Haens, G., Domènech, E., Eliakim, R., Eser, A., Frater, J., et al. (2009) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2009.02.010 · Cited by 1,247 · see citing works
Self-citationFaubion, W. A., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26279 · Cited by 1,144 · see citing works
Rembacken, B., Snelling, A. M., Hawkey, P. M., Chalmers, D. M., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,100 · see citing works
Järnerot, G., Hertervig, E., Friis–Liby, I., Blomquist, L., Karlén, P., Grännö, C., VILIEN, M., Ström, M., Danielsson, Å., Verbaan, H., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.003 · Cited by 1,092 · see citing works
Panaccione, R., Ghosh, S. K., Middleton, S. J., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.052 · Cited by 973 · see citing works
Sandborn, W. J., Feagan, B. G., Marano, C. W., Zhang, H., Strauss, R. S., Johanns, J., Adedokun, O. J., Guzzo, C. A., Colombel, J., Reinisch, W., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.048 · Cited by 944 · see citing works
Rahier, J., Magro, F., Abreu, C., Armuzzi, A., Ben‐Horin, S., Chowers, Y., Cottone, M., de Ridder, L., Doherty, G. A., Ehehalt, R., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.12.013 · Cited by 925 · see citing works
Self-citationRossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.045 · Cited by 921 · see citing works
Colombel, J., Rutgeerts, P. J., Reinisch, W., Esser, D., Wang, Y., Lang, Y., Marano, C. W., Strauss, R. S., Oddens, B. J., Feagan, B. G., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.054 · Cited by 918 · see citing works
Reinisch, W., Sandborn, W. J., Hommes, D. W., D’Haens, G., Hanauer, S. B., Schreiber, S., Panaccione, R., Fedorak, R. N., Tighe, M. B., Huang, B., et al. (2011) · Gut · doi:10.1136/gut.2010.221127 · Cited by 891 · see citing works
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Casteele, N. V., Ferrante, M., Assche, G. V., Ballet, V., Compernolle, G., Steen, K. V., Simoens, S., Rutgeerts, P. J., Gils, A., & Vermeire, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.031 · Cited by 889 · see citing works
Harbord, M., Annese, V., Vavricka, S. R., Allez, M., Acosta, M. B., Boberg, K. M., Burisch, J. M., Vos, M. D., de Vries, A., Dick, A. D., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv213 · Cited by 827 · see citing works
Self-citationTofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S. K., Panés, J., Vranic, I. I., Su, C. G., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800 · see citing works
Predicting outcome in severe ulcerative colitis.
Travis, S. P. L., Farrant, J. M., Ricketts, C., Nolan, D. J., Mortensen, N. M., Kettlewell, M. G. W., & Jewell, D. P. (1996) · Gut · doi:10.1136/gut.38.6.905 · Cited by 787 · see citing works
Cleynen, I., Boucher, G., Jostins, L., Schumm, L. P., Zeißig, S., Ahmad, T., Andersen, V. C., Andrews, J. M., Annese, V., Brand, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00465-1 · Cited by 784 · see citing works
Kruis, W., SCHÜTZ, E., Fric, P., Fixa, B., Judmaier, G., & Stolte, M. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00225.x · Cited by 774 · see citing works
Sandborn, W. J., Feagan, B. G., Marano, C. W., Zhang, H., Strauss, R. S., Johanns, J., Adedokun, O. J., Guzzo, C. A., Colombel, J., Reinisch, W., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.010 · Cited by 730 · see citing works
Solberg, I. C., Lygren, I., Jahnsen, J., Aadland, E., Høie, O., Cvancarova, M., Bernklev, T., Henriksen, M., Sauar, J., Vatn, M. H., et al. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802600961 · Cited by 729 · see citing works
Grainge, M. J., West, J., & Card, T. R. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61963-2 · Cited by 729 · see citing works
Turner, D., Walsh, C. M., Steinhart, A. H., & Griffiths, A. M. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.033 · Cited by 659 · see citing works
Yoo, D., Hrycaj, P., Miranda, P., Ramiterre, E., Piotrowski, M., Shevchuk, S. V., Kovalenko, V., Prodanović, N., Abello-Banfi, M., Gutiérrez-Ureña, S. R., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203090 · Cited by 654 · see citing works
Laharie, D., Bourreille, A., Branche, J., Allez, M., Bouhnik, Y., Filippi, J., Zerbib, F., Savoye, G., Nachury, M., Moreau, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61084-8 · Cited by 644 · see citing works
Self-citationDignass, A. U., Gasché, C., Bettenworth, D., Birgegård, G., Danese, S., Gisbert, J. P., Gomollón, F., Iqbal, T. H., Katsanos, K. H., Κoutroubakis, I. E., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jju009 · Cited by 635 · see citing works
Self-citationThe efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review
Fraser, A. G. (2002) · Gut · doi:10.1136/gut.50.4.485 · Cited by 631 · see citing works
Maser, E. A., Villela, R., Silverberg, M. S., & Greenberg, G. R. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.06.025 · Cited by 613 · see citing works
Park, W., Hrycaj, P., Jeka, S., Kovalenko, V., Lysenko, G., Miranda, P., Mikažāne, H., Gutiérrez-Ureña, S. R., Lim, M. J., Lee, Y.-A., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-203091 · Cited by 607 · see citing works
Impact of Clostridium difficile on Inflammatory Bowel Disease
Issa, M., Vijayapal, A., Graham, M. B., Beaulieu, D. B., Otterson, M. F., Lundeen, S. J., Skaros, S., Weber, L. R., KOMOROWSKI, R. A., Knox, J. F., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.028 · Cited by 570 · see citing works
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis
Kane, S. V., Huo, D., Aikens, J. E., & Hanauer, S. B. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01383-9 · Cited by 568 · see citing works
Microscopic activity in ulcerative colitis: what does it mean?
Riley, S. A., Mani, V., Goodman, M. J., Dutt, S., & Herd, M. E. (1991) · Gut · doi:10.1136/gut.32.2.174 · Cited by 562 · see citing works
INTENSIVE INTRAVENOUS REGIMEN FOR SEVERE ATTACKS OF ULCERATIVE COLITIS
Truelove, S. C., & Jewell, D. P. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90552-2 · Cited by 549 · see citing works
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
Timmer, A., Patton, P. H., Chande, N., McDonald, J. W., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000478.pub4 · Cited by 529 · see citing works
Ardizzone, S., Maconi, G., Russo, A., Imbesi, V., Colombo, E., & Porro, G. B. (2005) · Gut · doi:10.1136/gut.2005.068809 · Cited by 503 · see citing works
Assche, G. V., Magdelaine–Beuzelin, C., D’Haens, G., Baert, F., Noman, M., Vermeire, S., Ternant, D., Watier, H., Paintaud, G., & Rutgeerts, P. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.004 · Cited by 493 · see citing works
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Wang, Y., Parker, C. E., Bhanji, T., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub4 · Cited by 492 · see citing works
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
Bitton, A., Peppercorn, M. A., Antonioli, D. A., Niles, J. L., Shah, S. A., Bousvaros, A., Ransil, B. J., Wild, G., Cohen, A., Edwardes, M. D. D., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.20912 · Cited by 489 · see citing works
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis
Wang, Y., Parker, C. E., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000544.pub4 · Cited by 482 · see citing works
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
Zocco, M. A., Verme, L. Z. D., Cremonini, F., Piscaglia, A. C., Nista, E. C., Candelli, M., Novi, M., Rigante, D., Cazzato, I. A., Ojetti, V., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02927.x · Cited by 472 · see citing works
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
Ogata, H., Matsui, T., Nakamura, M., Iida, M., Takazoe, M., Suzuki, Y., & Hibi, T. (2006) · Gut · doi:10.1136/gut.2005.081794 · Cited by 462 · see citing works
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.
Hawthorne, A. B., Logan, R. F., Hawkey, C. J., Foster, P. N., Axon, A. T. R., Swarbrick, E. T., Scott, B. B., & Lennard‐Jones, J. E. (1992) · BMJ · doi:10.1136/bmj.305.6844.20 · Cited by 451 · see citing works
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
Sandborn, W. J., Feagan, B. G., Wolf, D. C., D’Haens, G., Vermeire, S., Hanauer, S. B., Ghosh, S. K., Smith, H., Cravets, M. W., Frohna, P., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513248 · Cited by 451 · see citing works
Brandse, J. F., BRINK, G. R. V. D., Wildenberg, M. E., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.016 · Cited by 434 · see citing works
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis
Kane, S. V., Cohen, R. D., Aikens, J. E., & Hanauer, S. B. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04683.x · Cited by 429 · see citing works
Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study
Sands, B. E., Tremaine, W. J., Sandborn, W. J., Rutgeerts, P. J., Hanauer, S. B., Mayer, L., Targan, S. R., & Podolsky, D. K. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200105000-00001 · Cited by 420 · see citing works
Bressler, B. L., Marshall, J. K., Bernstein, C. N., Bitton, A., Jones, J., Leontiadis, G. I., Panaccione, R., Steinhart, A. H., Tse, F., Feagan, B. G., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.001 · Cited by 414 · see citing works
Nguyen, G. C., Kaplan, G. G., Harris, M. L., & Brant, S. R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01780.x · Cited by 400 · see citing works
D’Haens, G., Lemmens, L., Nevens, F., Hiele, M. I., Rutgeerts, P. J., Vandeputte, L., Peeters, M., Vermeire, S., Geboes, K., Acker, F. V., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23983 · Cited by 392 · see citing works
Colombel, J., Loftus, E. V., Tremaine, W. J., Pembérton, J. H., Wolff, B. G., Young‐Fadok, T. M., Harmsen, W. S., Schleck, C. D., & Sandborn, W. J. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04148.x · Cited by 381 · see citing works
Randomized Controlled Trial of the Effect of Bifidobacteria-Fermented Milk on Ulcerative Colitis
Ishikawa, H., Akedo, I., Umesaki, Y., Tanaka, R., Imaoka, A., & Otani, T. (2003) · Journal of the American College of Nutrition · doi:10.1080/07315724.2003.10719276 · Cited by 369 · see citing works
Shen, J., Zuo, Z.-X., & Mao, A.-P. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000437495.30052.be · Cited by 364 · see citing works
Shah, S. C., Colombel, J., Sands, B. E., & Narula, N. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.01.015 · Cited by 362 · see citing works
Intravenous Cyclosporin in Ulcerative Colitis: A Five-Year Experience
Cohen, R. D., Stein, R., & Hanauer, S. B. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01149.x · Cited by 361 · see citing works
CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITIS
Misiewicz, J. J., Lennard‐Jones, J. E., Connell, A. M., Baron, J. H., & Jones, F. A. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90972-4 · Cited by 360 · see citing works
Marteau, P. R., Probert, C. S., Lindgren, S. C., Gassul, M., Tg, T., Dignass, A., Befrits, R., Midhagen, G., Rademaker, J., & FOLDAGER, M. (2005) · Gut · doi:10.1136/gut.2004.060103 · Cited by 360 · see citing works
Self-citationNguyen, G. C., Bernstein, C. N., Bitton, A., Chan, A. K. C., Griffiths, A. M., Leontiadis, G. I., Geerts, W. H., Bressler, B. L., Butzner, J. D., Carrier, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.042 · Cited by 354 · see citing works
Once-Daily, High-Concentration MMX Mesalamine in Active Ulcerative Colitis
Kamm, M. A., Sandborn, W. J., Gassull, M. A., Schreiber, S., Jackowski, L., Butler, T., Lyne, A., Stephenson, D., Palmen, M. J. H. J., & Joseph, R. E. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.011 · Cited by 352 · see citing works
Dissanayake, A. S., & Truelove, S. C. (1973) · Gut · doi:10.1136/gut.14.12.923 · Cited by 342 · see citing works
Intensive intravenous treatment of ulcerative colitis
Järnerot, G., Rolny, P., & Sandberg–Gertzén, H. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90201-x · Cited by 337 · see citing works
Nanda, K. S., Cheifetz, A. S., & Moss, A. C. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.363 · Cited by 336 · see citing works
Azathioprine in Ulcerative Colitis: Final Report on Controlled Therapeutic Trial
Jewell, D. P., & Truelove, S. C. (1974) · BMJ · doi:10.1136/bmj.4.5945.627 · Cited by 335 · see citing works
Gisbert, J. P., Marín, A. C., McNicholl, A. G., & Chaparro, M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13083 · Cited by 321 · see citing works
Hanauer, S. B., Sandborn, W. J., Kornbluth, A. A., Katz, S., Safdi, M. A., Woogen, S. D., Regalli, G., Yeh, C., Smith-Hall, N., & Ajayi, F. O. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00248.x · Cited by 320 · see citing works
Yanai, H. A., Lichtenstein, L., Assa, A., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.029 · Cited by 316 · see citing works
Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis.
Marshall, J. K., & Irvine, E. J. (1997) · Gut · doi:10.1136/gut.40.6.775 · Cited by 315 · see citing works
Sinha, A., Nightingale, J. M. D., West, K. P., Berlanga-Acosta, J., & Playford, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013136 · Cited by 303 · see citing works
Kappelman, M. D., Horváth–Puhó, E., Sandler, R. S., Rubin, D. T., Ullman, T. A., Pedersen, L. H., Baron, J. A., & Sørensen, H. T. (2011) · Gut · doi:10.1136/gut.2010.228585 · Cited by 303 · see citing works
Moskovitz, D. N., Assche, G. V., Maenhout, B., Arts, J., Ferrante, M., Vermeire, S., & Rutgeerts, P. J. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.04.001 · Cited by 296 · see citing works
Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis
Ford, A. C., Achkar, J., Khan, K. J., Kane, S. V., Talley, N. J., Marshall, J. K., & Moayyedi, P. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.67 · Cited by 295 · see citing works
Oren, R., Arber, N., Odes, S., Moshkowitz, M., Keter, D., Pomeranz, I. S., Ron, Y., Reisfeld, I., Broide, E., Lavy, A., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613046 · Cited by 295 · see citing works
Self-citationTakeuchi, K., Smale, S., Premchand, P., Maiden, L., Sherwood, R., Thjódleifsson, B., Björnsson, E., & Bjarnason, I. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00980-8 · Cited by 293 · see citing works
Out-patient Treatment of Ulcerative Colitis
Baron, J. H., Connell, A. M., Kanaghinis, T., Lennard‐Jones, J. E., & Jones, F. A. (1962) · BMJ · doi:10.1136/bmj.2.5302.441 · Cited by 291 · see citing works
Ho, G., Mowat, C., Goddard, C., Fennell, J., Shah, N., Prescott, R. J., & Satsangi, J. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01945.x · Cited by 287 · see citing works
Chapman, R. W., Selby, W. S., & Jewell, D. P. (1986) · Gut · doi:10.1136/gut.27.10.1210 · Cited by 285 · see citing works
Breuer, R. I., Soergel, K. H., Lashner, B. A., Christ, M. L., Hanauer, S. B., Vanagunas, A., Harig, J. M., Keshavarzian, A., ROBINSON, M. G., Sellin, J. H., et al. (1997) · Gut · doi:10.1136/gut.40.4.485 · Cited by 282 · see citing works
Roblin, X., Marotte, H., Rinaudo, M., Tedesco, É. D., Carla-Moreau, A., Phelip, J., Genin, C., Peyrin‐Biroulet, L., & Paul, S. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.010 · Cited by 277 · see citing works
Lindgren, S. C., Flood, L., Kilander, A. F., Löfberg, R., Persson, T., & Sjödahl, R. I. (1998) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199810000-00003 · Cited by 274 · see citing works
Williams, J. G., Alam, M. F., Alrubaiy, L., Arnott, I. D., Clement, C., Cohen, D. R., Gordon, J. N., Hawthorne, A. B., Hilton, M., Hutchings, H. A., et al. (2016) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30003-6 · Cited by 271 · see citing works
Self-citationLichtenstein, G. R., Kamm, M. A., Boddu, P., Gubergrits, N. B., Lyne, A., Butler, T., Lees, K., Joseph, R. E., & Sandborn, W. J. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.10.025 · Cited by 268 · see citing works
Gibson, D. J., Heetun, Z. S., Redmond, C. E., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.07.041 · Cited by 267 · see citing works
Travis, S. P. L., Danese, S., Kupčinskas, L., Alexeeva, O., D’Haens, G., Gibson, P. R., Moro, L., Jones, R., Ballard, E. D., Masure, J. A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304258 · Cited by 262 · see citing works
Controlled trial of bowel rest in the treatment of severe acute colitis.
McIntyre, P. B., Powell-Tuck, J., Wood, S., Lennard‐Jones, J. E., Lerebours, É., Hecketsweiler, P., Galmiche, J. P., & Colin, R. (1986) · Gut · doi:10.1136/gut.27.5.481 · Cited by 255 · see citing works
Clostridium difficile and inflammatory bowel disease
Issa, M., Ananthakrishnan, A. N., & Binion, D. G. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20500 · Cited by 253 · see citing works
Randall, J. K., Singh, B., Warren, B. F., Travis, S. P. L., Mortensen, N. J. M., & George, B. D. (2010) · British journal of surgery · doi:10.1002/bjs.6874 · Cited by 252 · see citing works
ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
Danese, S., Fiorino, G., Raine, T., Ferrante, M., Kemp, K., Kierkuś, J., Lakatos, P. L., Mantzaris, G. J., van der Woude, C. J., Panés, J., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw198 · Cited by 251 · see citing works
Self-citationFerrante, M., D’Hoore, A. J. L., Vermeire, S., Declerck, S., Noman, M., Assche, G. V., Hoffman, I. E. A., Rutgeerts, P., & PENNINCKX, F. M. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20863 · Cited by 248 · see citing works
Sandborn, W. J., Travis, S. P. L., Moro, L., Jones, R., Gautille, T., Bagin, R. G., Huang, M., Yeung, P., & Ballard, E. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.003 · Cited by 245 · see citing works
Jonkers, D., Penders, J., Masclee, A., & Pierik, M. (2012) · Drugs · doi:10.2165/11632710-000000000-00000 · Cited by 240 · see citing works
Outcome of cytomegalovirus infections in patients with inflammatory bowel disease
Papadakis, K., Tung, J. K., Binder, S. W., et al. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.03949.x · Cited by 238 · see citing works
Kishore, J., Ghoshal, U., Ghoshal, U. C., Krishnani, N., Kumar, S., Singh, M., & Ayyagari, A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45629-0 · Cited by 237 · see citing works
Gan, S. I., & Beck, P. L. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07696.x · Cited by 232 · see citing works
Kunitake, H., Hodin, R. A., Shellito, P. C., Sands, B. E., Korzenik, J. R., & Bordeianou, L. (2008) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-008-0630-8 · Cited by 230 · see citing works
Feagan, B. G., Rubin, D. T., Danese, S., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.044 · Cited by 229 · see citing works
Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis
Lawson, M., Thomas, A. G., & Akobeng, A. K. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005112.pub2 · Cited by 229 · see citing works
Maté-Jiménez, J., Hermida, C., Perona, J. C., & Moreno‐Otero, R. (2000) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200012110-00010 · Cited by 228 · see citing works
Psychosocial determinants of relapse in ulcerative colitis: A longitudinal study
Bitton, A., Sewitch, M. J., Peppercorn, M. A., de B Edwardes, M. D., Shah, S., Ransil, B., & Locke, S. E. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07717.x · Cited by 226 · see citing works
Lennard‐Jones, J. E., Longmore, A. J., Newell, A. C., Wilson, C. W. E., & Jones, F. A. (1960) · Gut · doi:10.1136/gut.1.3.217 · Cited by 226 · see citing works
The long-term outcome of ulcerative colitis treated with 6-mercaptopurine.
George, J. M., Present, D. H., Pou, R., Bodian, C., & Rubin, P. (1996) · PubMed · Cited by 225 · see citing works
Torres, J., Boyapati, R. K., Kennedy, N. A., Louis, E. J., Colombel, J., & Satsangi, J. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.055 · Cited by 225 · see citing works
Long-term outcome after infliximab for refractory ulcerative colitis
Ferrante, M., Vermeire, S., Fidder, H. H., Schnitzler, F., Noman, M., Assche, G. V., Hertogh, G. D., Hoffman, I. E. A., D’Hoore, A., Steen, K. V., et al. (2008) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2008.03.004 · Cited by 222 · see citing works
Long-term Efficacy of Vedolizumab for Ulcerative Colitis
Loftus, E. V., Colombel, J., Feagan, B. G., Vermeire, S., Sandborn, W. J., Sands, B. E., Danese, S., D’Haens, G., Kaser, A., Panaccione, R., et al. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw177 · Cited by 222 · see citing works
Ogata, H., Kato, J., Hirai, F., Hida, N., Matsui, T., Matsumoto, T., Koyanagi, K., & Hibi∥, T. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21853 · Cited by 212 · see citing works
Review article: defining remission in ulcerative colitis
Travis, S. P. L., Higgins, P., Orchard, T. R., van der Woude, C. J., Panaccione, R., Bitton, A., O'Morain, C. A., Panés, J., Sturm, A., Reinisch, W., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04701.x · Cited by 211 · see citing works
Domènech, E., Vega, R., Ojanguren, I., Hernández, Á., García-Planella, E., Bernal, I., Rosinach, M., Boix, J., Cabré, E., & Gassull, M. A. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20498 · Cited by 210 · see citing works
Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies
Reinisch, W., Sandborn, W. J., Rutgeerts, P. J., Feagan, B. G., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., de Villiers, W. J. S., BLANK, M. A., Lang, Y., et al. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21697 · Cited by 208 · see citing works
Ciclosporin use in acute ulcerative colitis
Campbell, S. S., Travis, S. P. L., & Jewell, D. P. (2005) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200501000-00016 · Cited by 206 · see citing works
Assessment of severity in colitis: a preliminary study.
Lennard‐Jones, J. E., Ritchie, J. K., Hilder, W., & Spicer, C. C. (1975) · Gut · doi:10.1136/gut.16.8.579 · Cited by 205 · see citing works
Treatment of distal ulcerative colitis with short-chain fatty acid enemas a placebo-controlled trial
Scheppach, W. M., & German-Austrian Scfa Study Group (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02071409 · Cited by 204 · see citing works
Kruis, W., Kiudelis, G., Rácz, I. A., Gorelov, I. A., Pokrotnieks, J., Horyński, M., Bátovský, M., Kykal, J., Boehm, S. A., Greinwald, R., et al. (2008) · Gut · doi:10.1136/gut.2008.154302 · Cited by 204 · see citing works
Gisbert, J. P., Marín, A. C., & Chaparro, M. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.54 · Cited by 202 · see citing works
Brandse, J. F., Mathôt, R. A. A., van der Kleij, D., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.10.029 · Cited by 201 · see citing works
Biological Agents for Moderately to Severely Active Ulcerative Colitis
Danese, S., Fiorino, G., Peyrin‐Biroulet, L., Lucenteforte, E., Virgili, G., Moja, L., & Bonovas, S. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2403 · Cited by 198 · see citing works
Probiotics for induction of remission in ulcerative colitis
Mallon, P. T., McKay, D., Kirk, S. J., & Gardiner, K. R. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005573.pub2 · Cited by 197 · see citing works
Comparison of Corticosteroid and Sulphasalazine Therapy in Ulcerative Colitis
Truelove, S. C., Watkinson, G., & Draper, G. J. (1962) · BMJ · doi:10.1136/bmj.2.5321.1708 · Cited by 194 · see citing works
Probiotics for maintenance of remission in ulcerative colitis
Iheozor‐Ejiofor, Z., Kaur, L., Gordon, M. A., Baines, P. A., Sinopoulou, V., & Akobeng, A. K. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007443.pub3 · Cited by 193 · see citing works
Predictors of early response to infliximab in patients with ulcerative colitis
Ferrante, M., Vermeire, S., Katsanos, K. H., Noman, M., Assche, G. V., Schnitzler, F., Arijs, I., Hertogh, G. D., Hoffman, I. E. A., Geboes, K. J., et al. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20054 · Cited by 192 · see citing works
Self-citationGreen, J. R. B., Lobo, A., Holdsworth, C. D., Leicester, R. J., Gibson, J. A., Kerr, G. D., Hodgson, H. J. F., Parkins, K. J., & Taylor, M. D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70627-4 · Cited by 191 · see citing works
Mulder, C. J. J., Fockens, P., Meijer, J. W. R., van der Heide, H., Wiltink, H. H., & Tytgat, G. N. J. (1996) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199606000-00010 · Cited by 191 · see citing works
Baumgart, D. C., Bokemeyer, B., Drabik, A., Stallmach, A., & Schreiber, S. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13594 · Cited by 187 · see citing works
Gecse, K. B., Lovasz, B. D., Farkas, K., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv220 · Cited by 183 · see citing works
Why do patients with ulcerative colitis relapse?
Riley, S. A., Mani, V., Goodman, M. J., & Lucas, S. B. (1990) · Gut · doi:10.1136/gut.31.2.179 · Cited by 182 · see citing works
Baumgart, D. C., Pintoffl, J. P., Sturm, A., Wiedenmann, B. J., & Dignass, A. U. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00524.x · Cited by 182 · see citing works
Self-citationCyclosporine A for induction of remission in severe ulcerative colitis
Shibolet, O., Regushevskaya, E., Brezis, M., & Soares‐Weiser, K. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004277.pub2 · Cited by 182 · see citing works
Gustavsson, A., Järnerot, G., Hertervig, E., Friis–Liby, I., Blomquist, L., Karlén, P., Grännö, C., VILIEN, M., Ström, M., Verbaan, H., et al. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04435.x · Cited by 181 · see citing works
Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis
Marshall, J. K., Thabane, M. E., Steinhart, A. H., Newman, J. R., Anand, A., & Irvine, E. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004115.pub2 · Cited by 180 · see citing works
Kamm, M. A., Lichtenstein, G. R., Sandborn, W. J., Schreiber, S., Lees, K., Barrett, K., & Joseph, R. J. (2008) · Gut · doi:10.1136/gut.2007.138248 · Cited by 177 · see citing works
The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis.
Adler, D. J., & Korelitz, B. I. (1990) · PubMed · Cited by 173 · see citing works
Riley, S. A., Mani, V., Goodman, M. J., Herd, M. E., Dutt, S., & Turnberg, L. A. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90677-4 · Cited by 173 · see citing works
Mantzaris, G. J., Hatzis, A., Kontogiannis, P., & Triadaphyllou, G. (1994) · PubMed · Cited by 171 · see citing works
D'Albasio, G., Pacini, F., Camarri, E., Messori, A., Trallori, G., Bonanomi, A. G., Bardazzi, G., Milla, M., Ferrero, S., Biagini, M., et al. (1997) · PubMed · Cited by 170 · see citing works
Bitton, A., Buie, D. W., Enns, R. A., Feagan, B. G., Jones, J., Marshall, J. K., Whittaker, S., Griffiths, A. M., & Panaccione, R. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.386 · Cited by 170 · see citing works
Kohn, A., Daperno, M., Armuzzi, A., Cappello, M., Biancone, L., Orlando, A., Viscido, A., Annese, V., Riegler, G., Meucci, G., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03415.x · Cited by 169 · see citing works
Roberts, S., Williams, J. G., Yeates, D., & Goldacre, M. J. (2007) · BMJ · doi:10.1136/bmj.39345.714039.55 · Cited by 169 · see citing works
Colombel, J., Sandborn, W. J., Ghosh, S. K., Wolf, D. C., Panaccione, R., Feagan, B. G., Reinisch, W., Robinson, A. M., Lazar, A., Kron, M., et al. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.242 · Cited by 166 · see citing works
Zenlea, T., Yee, E. U., Rosenberg, L., Boyle, M., Nanda, K. S., Wolf, J. L., Falchuk, K. R., Cheifetz, A. S., Goldsmith, J. D., & Moss, A. C. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.50 · Cited by 165 · see citing works
Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis
Sandborn, W. J., Targan, S. R., Byers, V. S., Rutty, D., Mu, H., Zhang, X., & Tang, T. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.340 · Cited by 161 · see citing works
Ford, A. C., Khan, K. J., Achkar, J., & Moayyedi, P. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.410 · Cited by 157 · see citing works
Fernández‐Bañares, F., Bertrán, X., Esteve, M., Cabré, E., Menacho, M., Humbert, P., Planas, R., & Gassull, M. A. (1996) · PubMed · Cited by 154 · see citing works
Dignass, A. U., Bokemeyer, B., Adamek, H. E., Mross, M. R., Vinter‐Jensen, L., Börner, N., Silvennoinen, J., Tan, G., Pool, M. O., Stijnen, T., et al. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.04.004 · Cited by 154 · see citing works
Self-citationOral budesonide for induction of remission in ulcerative colitis
Sherlock, M. E., MacDonald, J. K., Griffiths, A. M., Steinhart, A. H., & Seow, C. H. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007698.pub3 · Cited by 151 · see citing works
Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis
Gionchetti, P., Rizzello, F., Venturi, A., Ferretti, M., Brignola, C., Miglioli, M., & Campieri, M. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02236902 · Cited by 147 · see citing works
Clostridium difficile Infection in the Inflammatory Bowel Disease Patient
Berg, A. M., Kelly, C. P., & Farraye, F. A. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22964 · Cited by 146 · see citing works
Carbonnel, F., Colombel, J., Filippi, J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.10.050 · Cited by 144 · see citing works
Self-citationSandborn, W. J., Korzenik, J. R., Lashner, B. A., Leighton, J. A., Mahadevan, U., Marion, J. F., Safdi, M. A., Sninsky, C. A., Patel, R. M., Friedenberg, K., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.054 · Cited by 144 · see citing works
Autenrieth, D., & Baumgart, D. C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21847 · Cited by 143 · see citing works
Lees, C. W., Heys, D., Ho, G., Noble, C. L., Shand, A. G., Mowat, C., Boulton-Jones, R., WILLIAMS, A., Church, N. G., Satsangi, J., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03383.x · Cited by 140 · see citing works
Corte, C., Fernandopulle, N., Catuneanu, A. M., Burger, D. C., Cesarini, M., White, L., Keshav, S., & Travis, S. P. L. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv047 · Cited by 140 · see citing works
Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis
Carbonnel, Gargouri, Lémann, M., Beaugerie, Cattan, Cosnes, & Gendre (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00705.x · Cited by 139 · see citing works
Ben‐Horin, S., Margalit, M., Bossuyt, P. J., Maul, J., Shapira, Y., Bojic, D., Chermesh, I., Al‐Rifai, A., Schoepfer, A. M., Bosani, M., et al. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.05.031 · Cited by 139 · see citing works
Self-citationYang, Z., Wu, Q., Wu, K., & Fan, D. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04204.x · Cited by 136 · see citing works
Sandborn, W. J., Tremaine, W. J., Schroeder, K. W., Batts, K. P., Lawson, G. M., Steiner, B. L., Harrison, J. M., & ZINSMEISTER, A. R. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90394-8 · Cited by 135 · see citing works
Pentasa UC Maintenance Study Group, Miner, P. B., Hanauer, S. B., ROBINSON, M. G., Schwartz, J., & Arora, S. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02065413 · Cited by 135 · see citing works
Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis
Sang, L.-X. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i15.1908 · Cited by 133 · see citing works
Intravenous cyclosporine in attacks of ulcerative colitis
Carbonnel, F., Boruchowicz, A., Duclos, B., Soulé, J. C., Lerebours, É., Lémann, M., Bélaïche, J., Colombel, J., Cosnes, J., & Gendre, J. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02100145 · Cited by 131 · see citing works
Self-citationHigh-Dose Methylprednisolone in the Treatment of Active Ulcerative Colitis
Rosenberg, W., Ireland, A., & Jewell, D. P. (1990) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199002000-00011 · Cited by 130 · see citing works
Kefalakes, H., Stylianides, T. J., Amanakis, G., & Kolios, G. C. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0719-3 · Cited by 130 · see citing works
Navaneethan, U., Mukewar, S. S., Venkatesh, P. G. K., López, R., & Shen, B. (2011) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2011.09.005 · Cited by 129 · see citing works
Wright, R., & Truelove, S. (1966) · Digestive Diseases and Sciences · doi:10.1007/bf02233941 · Cited by 128 · see citing works
Henker, J., Muller, S., Laass, M., Schreiner, A., & Schulze, J. (2008) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2008-1027463 · Cited by 128 · see citing works
Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease
Reinink, A. R., Lee, T. C., & Higgins, P. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000816 · Cited by 126 · see citing works
Cassinotti, A., Actis, G. C., Duca, P., Massari, A., Colombo, E. M., Gai, E., Annese, V., D'Albasio, G., Manes, G., Travis, S. P. L., et al. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.410 · Cited by 125 · see citing works
Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications
Hyde, G. M., Jewell, D. P., Kettlewell, M. G. W., & Mortensen, N. J. M. C. (2001) · Diseases of the Colon & Rectum · doi:10.1007/bf02234594 · Cited by 125 · see citing works
Lynch, R. W., Lowe, D., Protheroe, A., Driscoll, R., Rhodes, J. M., & Arnott, I. D. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12473 · Cited by 124 · see citing works
Panccione, R., Ghosh, S. K., Middleton, S. J., Márquez, J. R., Халиф, И. Л., Flint, L., van Hoogstraten, H., Zheng, H., Danese, S., & Rutgeerts, P. J. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)60548-9 · Cited by 120 · see citing works
Jen, M., Saxena, S. K., Bottle, A., Aylin, P. P., & Pollok, R. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04661.x · Cited by 119 · see citing works
Regueiro, M. D., Loftus, E. V., Steinhart, H., & Cohen, R. D. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000231495.92013.5e · Cited by 117 · see citing works
Karner, M., Kocjan, A., Stein, J. M., Schreiber, S., von Boyen, G. B. T., Uebel, P., Schmidt, C., Kupčinskas, L., Dina, I., Zuelch, F., et al. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.104 · Cited by 117 · see citing works
Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006
Jakobovits, S. L., Jewell, D. P., & Travis, S. P. L. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03300.x · Cited by 116 · see citing works
Long‐term effect of tacrolimus therapy in patients with refractory ulcerative colitis
YAMAMOTO, S., Nakase, H., MIKAMI, S., Inoue, S., Yoshino, T., Takeda, Y., Kasahara, K., UENO, S., Uza, N., Kitamura, H., et al. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03764.x · Cited by 115 · see citing works
The efficacy of methotrexate for maintaining remission in inflammatory bowel disease
Fraser, A. G., Morton, D., McGovern, D. P. B., Travis, S. P. L., & Jewell, D. P. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01227.x · Cited by 114 · see citing works
Travis, S. P. L., Satsangi, J., & Lémann, M. (2010) · Gut · doi:10.1136/gut.2010.216895 · Cited by 111 · see citing works
Azathioprine in Steroid-Resistant and Steroid-Dependent Ulcerative Colitis
Ardizzone, S., Molteni, F., Imbesi, V., Bollani, S., & Porro, G. B. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199707000-00007 · Cited by 111 · see citing works
Reinisch, W., Sandborn, W. J., Panaccione, R., Huang, B., Pollack, P. F., Lazar, A., & Thakkar, R. B. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f2b7 · Cited by 110 · see citing works
Kane, S. V., Huo, D., & Magnanti, K. (2003) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)70032-9 · Cited by 110 · see citing works
Sandborn, W. J., Bosworth, B. P., Zakko, S. F., Gordon, G. L., Clemmons, D. R., Golden, P. L., Rolleri, R. L., Yu, J., Barrett, A. C., Bortey, E. B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.037 · Cited by 109 · see citing works
The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis
Sood, A., Kaushal, V., Midha, V., Bhatia, K. L., Sood, N., & Malhotra, V. (2002) · Journal of Gastroenterology · doi:10.1007/s005350200034 · Cited by 109 · see citing works
Feagan, B. G., Sandborn, W. J., Lazar, A., Thakkar, R. B., Huang, B., Reilly, N., Chen, N., Yang, M., Skup, M., Mulani, P. M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.032 · Cited by 108 · see citing works
Hebden, BLACKSHAW, Perkins, Wilson, & Spiller, R. E. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00697.x · Cited by 107 · see citing works
van Rheenen, P. V., Aloi, M., Biron, I., Carlsen, K., Cooney, R., Cucchiara, S., Cullen, G., Escher, J., Kierkuś, J., Lindsay, J., et al. (2017) · Journal of Crohn's & Colitis · doi:10.1093/ecco-jcc/jjx010 · Cited by 107 · see citing works
Self-citationBossa, F., Fiorella, S., Caruso, N., Accadia, L., Napolitano, G., Valvano, M. R., Andriulli, A., & Annese, V. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01007.x · Cited by 104 · see citing works
Gies, N., Kroeker, K. I., Wong, K., & Fedorak, R. N. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04380.x · Cited by 103 · see citing works
Small bowel gas in severe ulcerative colitis.
Chew, C. N., Nolan, D. J., & Jewell, D. P. (1991) · Gut · doi:10.1136/gut.32.12.1535 · Cited by 103 · see citing works
Campieri, M., Adamo, S., Valpiani, D., D’Arienzo, A., D'Albasio, G., Pitzalis, M. V., Cesari, P., Casetti, T., Castiglione, G. N., Rizzello, F., et al. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01609.x · Cited by 102 · see citing works
Long-Term Use of Mesalamine (Rowasa) Suppositories in Remission Maintenance of Ulcerative Proctitis
Hanauer, S. B., Good, L. I., Goodman, M. W., Pizinger, R. J., Strum, W. B., Lyss, C., Haber, G. B., Williams, N. C., & ROBINSON, M. G. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02185.x · Cited by 102 · see citing works
Marteau, P. R., Crand, J., Foucault, M., & Rambaud, J. C. (1998) · Gut · doi:10.1136/gut.42.2.195 · Cited by 102 · see citing works
Narcotic use for inflammatory bowel disease and risk factors during hospitalization
Long, M. D., Barnes, E. L., Herfarth, H. H., & Drossman, D. A. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21806 · Cited by 100 · see citing works
Predictive Factors of Response to Cyclosporine in Steroid-Refractory Ulcerative Colitis
Cacheux, W., Seksik, P., Lémann, M., Marteau, P. R., Nion–Larmurier, I., Afchain, P., Daniel, F. E., Beaugerie, L., & Cosnes, J. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01653.x · Cited by 100 · see citing works
Actis, G. C., Fadda, M., David, E., & Sapino, A. (2007) · BMC Gastroenterology · doi:10.1186/1471-230x-7-13 · Cited by 99 · see citing works
Wahed, M., Louis-Auguste, J., Baxter, L. M., Limdi, J. K., McCartney, S. A., Lindsay, J. O., & Bloom, S. L. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04073.x · Cited by 97 · see citing works
Dias, C. C., Rodrigues, P. P., Costa‐Pereira, A., et al. (2014) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jju016 · Cited by 97 · see citing works
Helminth therapy (worms) for induction of remission in inflammatory bowel disease
Garg, S. K., Croft, A. M., & Bager, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009400.pub2 · Cited by 96 · see citing works
Komaki, Y., Komaki, F., Ido, A., et al. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv221 · Cited by 93 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Barberio, B., Zamani, M., Black, C. J., Savarino, E. V., & Ford, A. C. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00014-5 · Cited by 758 · see citing works
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419 · see citing works
The Unregulated Probiotic Market
de Simone, C. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.01.018 · Cited by 317 · see citing works
Torres, J., Hu, J., Seki, A., Eisele, C., Nair, N., Huang, R., Tarassishin, L., Jharap, B., Cote-Daigneault, J., Mao, Q., et al. (2020) · Gut · doi:10.1136/gutjnl-2018-317855 · Cited by 218 · see citing works
Kedia, S., Virmani, S., K Vuyyuru, S., Kumar, P., Kante, B., Sahu, P., Kaushal, K., Farooqui, M., Singh, M., Verma, M., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327811 · Cited by 201 · see citing works
Sato, Y., Tsujinaka, S., Miura, T., Kitamura, Y., Suzuki, H., & Shibata, C. (2023) · Cancers · doi:10.3390/cancers15164154 · Cited by 111 · see citing works
Inflammatory bowel disease – non-biological treatment
Magro, F., Cordeiro, G., Dias, A. M., & Estevinho, M. M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105075 · Cited by 77 · see citing works
Long-term safety of approved biologics for ulcerative colitis
D’Amico, F., Parigi, T. L., Bonovas, S., Peyrin-Biroulet, L., & Danese, S. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1773430 · Cited by 29 · see citing works
Meijboom, R. W., Gardarsdottir, H., Egberts, T. C. G., & Giezen, T. J. (2022) · BioDrugs · doi:10.1007/s40259-021-00508-4 · Cited by 18 · see citing works
Mortlock, S., Lord, A., Montgomery, G., Zakrzewski, M., Simms, L. A., Krishnaprasad, K., Hanigan, K., Doecke, J. D., Walsh, A., Lawrance, I. C., et al. (2023) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjac121 · Cited by 12 · see citing works
- Authors
- Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., de Sousa, H. T., Dignass, A., Carbonnel, F., & for the European Crohn’s and Colitis Organisation [ECCO
- Affiliations
- Chelsea and Westminster Hospital (GB)
- Sheba Medical Center (IL)
- University Hospital Münster (DE)
- Department of Gastroenterology, Venizeleio General Hospital d , Heraklion, Crete , Greece
- University of Ioannina (GR)
- Tel Aviv University (IL)
- Klinikum Lüneburg (DE)
- University of Szeged (HU)
- University of Cambridge (GB)
- Hull University Teaching Hospitals NHS Trust (GB)
- Gastroenterology Department, Algarve Hospital Center; Biomedical Sciences & Medicine Department, University of Algarve k , Faro , Portugal
- Agaplesion Markus Hospital (DE)
- Université Paris-Sud (FR)
- Corresponding author
- Harbord, Marcus
- ORCID
- Venue
- Journal of Crohn's and Colitis
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01-28
- Volume
- 11
- Issue
- 7
- Pages
- 769-784
- ISSN
- 1873-9946 (ISSN-L)
- 1876-4479
- OpenAlex
- W4210662453
- Cited by
- 1,180
- References
- 309
- Citations by year
- 2026: 49 · 2025: 101 · 2024: 103 · 2023: 130 · 2022: 166 · 2021: 179 · 2020: 174 · 2019: 149 · 2018: 110 · 2017: 17
- FWCI
- 81.69
- Type
- journal article
- Language
- en
- Update notices
- expression_of_concern (2022-01-24)
- Open access
- bronze
- doi.org
- Locations
- Journal of Crohn s and Colitis (publishedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Epidemiology › Microscopic Colitis
- Keywords
- ulcerative colitis, proctitis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
